Von Willebrand factor propeptide in vascular disorders

被引:0
作者
van Mourik, JA
de Wit, TR
机构
[1] CLB, Dept Plasma Prot & Blood Coagual, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Von Willebrand factor; endothelial cells; von Willebrand factor propeptide; vascular disease; Weibel-Palade bodies;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand factor (VWF) is a multifunctional plasma protein that plays a prominent role in haemostasis. In endothelial cells, processing of its precursor pro-VWF results in the formation of two large polypeptides, mature VWF and a propeptide. These proteins are co-secreted on an equimolar basis but are cleared from the circulation at different rates. VWF levels are frequently elevated in response to vascular disorders. Similarly, propeptide levels are increased under these conditions, although primarily in fulminant vascular disease, such as thrombotic thrombocytopenic purpura and septicemia. In chronic vascular disease, e.g. diabetes or peripheral vascular disease, propeptide levels are much less elevated. The differential response of VWF and propeptide levels to vascular disease could provide a means to assess the extent and time course of endothelial cell activation. After secretion, the propeptide may play a role in modulating cellular adhesion processes. Thus, enhanced propeptide secretion seems not to be of merely diagnostic significance.
引用
收藏
页码:164 / 171
页数:8
相关论文
共 77 条
[41]   ELEVATED VONWILLEBRAND-FACTOR ANTIGEN IS AN EARLY PLASMA PREDICTOR OF ACUTE LUNG INJURY IN NONPULMONARY SEPSIS SYNDROME [J].
RUBIN, DB ;
WIENERKRONISH, JP ;
MURRAY, JF ;
GREEN, DR ;
TURNER, J ;
LUCE, JM ;
MONTGOMERY, AB ;
MARKS, JD ;
MATTHAY, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :474-480
[42]   Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study [J].
Rumley, A ;
Lowe, GDO ;
Sweetnam, PM ;
Yarnell, JWG ;
Ford, RP .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (01) :110-116
[43]   Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin [J].
Russell, FD ;
Skepper, JN ;
Davenport, AP .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (03) :424-430
[44]   Biochemistry and genetics of von Willebrand factor [J].
Sadler, JE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :395-424
[45]  
Sakai H, 2000, THROMB HAEMOSTASIS, V84, P204
[46]   Localization of α1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells [J].
Schnyder-Candrian, S ;
Borsig, L ;
Moser, R ;
Berger, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8369-8374
[47]  
SCOTT JP, 1981, BLOOD, V58, P1075
[48]  
SODETZ JM, 1979, J BIOL CHEM, V254, P754
[49]   DIFFERING POLARITY OF THE CONSTITUTIVE AND REGULATED SECRETORY PATHWAYS FOR VONWILLEBRAND-FACTOR IN ENDOTHELIAL-CELLS [J].
SPORN, LA ;
MARDER, VJ ;
WAGNER, DD .
JOURNAL OF CELL BIOLOGY, 1989, 108 (04) :1283-1289
[50]  
SPORN LA, 1987, BLOOD, V69, P1531